Phenylbutyrate

( DrugBank: - / KEGG DRUG: - )


7 diseases
IDDisease name (Link within this page)Number of trials
251Urea cycle disorder5
297Alagille syndrome2
338Progressive familial intrahepatic cholestasis2

2. Amyotrophic lateral sclerosis


Clinical trials : 786Drugs : 550 - (DrugBank : 182) / Drug target genes : 170 - Drug target pathways : 232 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

93. Primary biliary cholangitis


Clinical trials : 352Drugs : 206 - (DrugBank : 55) / Drug target genes : 40 - Drug target pathways : 119 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

94. Primary sclerosing cholangitis


Clinical trials : 177Drugs : 120 - (DrugBank : 48) / Drug target genes : 25 - Drug target pathways : 148 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

244. Maple syrup urine disease


Clinical trials : 3Drugs : 4 - (DrugBank : 3) / Drug target gene : 0 - Drug target pathway : 0
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

251. Urea cycle disorder


Clinical trials : 68Drugs : 50 - (DrugBank : 19) / Drug target genes : 2 - Drug target pathways : 4 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

297. Alagille syndrome


Clinical trials : 45Drugs : 15 - (DrugBank : 8) / Drug target genes : 3 - Drug target pathways : 5 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

338. Progressive familial intrahepatic cholestasis


Clinical trials : 62Drugs : 14 - (DrugBank : 5) / Drug target genes : 2 - Drug target pathways : 3 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries